Biomerica (BMRA) Change in Receivables (2010 - 2026)
Biomerica (BMRA) posted Change in Receivables of -$64000.0 for Q1 2026, up 71.81% sequentially from -$227000.0 in Q4 2025, and down 6.67% YoY from -$68571.4 in Q1 2025.
Biomerica (BMRA) Change in Receivables (2010 - 2026) Analysis & Trends
Biomerica has reported Change in Receivables for 17 years, with the latest figure at -$64000.0 in Q1 2026.
- Quarterly Change in Receivables fell 6.67% year-over-year to -$64000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$315000.0 (down 325.0% YoY) and the FY2025 annual result came in at -$209000.0, down 197.21% from the prior year.
- Change in Receivables improved to -$64000.0 in Q1 2026 per BMRA's latest filing, from -$227000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $708000.0 in Q3 2023 and troughed at -$536000.0 in Q2 2025.
- A 5-year average of $79850.0 and a median of $26015.0 in 2022 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 1687.43% in 2023, down 749.12% in 2023.
- Over 5 years, Change in Receivables stood at $57000.0 in 2022, then sank by 749.12% to -$370000.0 in 2023, then soared by 38.11% to -$229000.0 in 2024, then gained by 0.87% to -$227000.0 in 2025, then soared by 71.81% to -$64000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$64000.0, -$227000.0, and $512000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -64,000.00 |
| Feb 28, 2026 | -64,000.00 |
| Nov 30, 2025 | -227,000.00 |
| Nov 30, 2025 | -227,000.00 |
| Aug 31, 2025 | 512,000.00 |
| Aug 31, 2025 | 512,000.00 |
| May 31, 2025 | -536,000.00 |
| May 31, 2025 | -536,000.00 |
| Feb 28, 2025 | -60,000.00 |
| Feb 28, 2025 | -60,000.00 |
| Nov 30, 2024 | -229,000.00 |
| Nov 30, 2024 | -229,000.00 |
| Aug 31, 2024 | 616,000.00 |
| Aug 31, 2024 | 616,000.00 |
| May 31, 2024 | -187,000.00 |
| May 31, 2024 | -187,000.00 |
| Feb 29, 2024 | 64,000.00 |
| Feb 29, 2024 | 64,000.00 |
| Nov 30, 2023 | -370,000.00 |
| Nov 30, 2023 | -370,000.00 |